iTRAQ-coupled 2-D LC-MS/MS analysis of protein profile associated with HBV-modulated DNA methylation

Proteomics

Volumn 9, Issue 15, 2009, Pages 3856-3868

  Niu, Dandan ^a   Sui, Jianjun ^a   Zhang, Jianhua ^a   Feng, Huixing ^a   Chen, Wei Ning ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

DNA methylation; Hepatitis B virus; Hepatocellular carcinoma; LC MS MS analysis

Indexed keywords

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AZACITIDINE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DNA; DNA METHYLATION; DNA MODIFICATION METHYLASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; PROTEOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY;

HEPATITIS B VIRUS;

EID: 68549108046     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900071     Document Type: Article

References (44)

1. Park, I. Y., Sohn, B. H., Yu, E., Suh, D. J. et al., Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007, 132, 1476-1494.
2. Hellebrekers, D. M., Melotte, V., Vire, E., Langenkamp, E. et al., Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res. 2007, 67, 4138-4148.
3. Liu, J., Lian, Z., Han, S., Waye, M. M. et al., Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 2006, 25, 1008-1017.
4. Oh, B. K., Kim, H., Park, H. J., Shim, Y. H. et al., DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int. J. Mol. Med. 2007, 20, 65-73.
5. Zhong, S., Tang, M. W., Yeo, W., Liu, C. et al., Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin. Cancer Res. 2002, 8, 1087-1092.
6. Qiu, G. H., Salto-Tellez, M., Ross, J. A., Yeo, W. et al., The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle. J. Hepatol. 2007.
7. Chen, W. N., Oon, C. J., Leong, A. L., Koh, S., Teng, S. W., Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance. Biochem. Biophys. Res. Commun. 2000, 276, 885-892.
8. Jung, J. K., Arora, P., Pagano, J. S., Jang, K. L., Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 2007, 67, 5771-5778.
9. Zhang, Y. J., Wu, H. C., Shen, J., Ahsan, H. et al., Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin. Cancer Res. 2007, 13, 2378-2384.
10. Lee, J. O., Kwun, H. J., Jung, J. K., Choi, K. H. et al., Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 2005, 24, 6617-6625.
11. Tong, A., Wu, L., Lin, Q., Lau, Q. C. et al., Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model. Proteomics 2008, 8, 2012-2023.
12. Lilley, K. S., Razzaq, A., Dupree, P., Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation. Curr. Opin. Chem. Biol. 2002, 6, 46-50.
13. Tan, T. L., Chen, W. N., A proteomics analysis of cellular proteins associated with HBV genotype-specific HBX: potential in identification of early diagnostic markers for HCC. J. Clin. Virol. 2005, 33, 293-298.
14. Vogt, J. A., Schroer, K., Holzer, K., Hunzinger, C. et al., Protein abundance quantification in embryonic stem cells using incomplete metabolic labelling with 15N amino acids, matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, and analysis of relative isotopologue abundances of peptides. Rapid Commun. Mass Spectrom. 2003, 17, 1273-1282.
15. Zappacosta, F., Annan, R. S., N-terminal isotope tagging strategy for quantitative proteomics: results-driven analysis of protein abundance changes. Anal. Chem. 2004, 76, 6618-6627.
16. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 2004, 3, 1154-1169.
17. Dannenberg, L. O., Edenberg, H. J., Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics 2006, 7, 181.
18. Sui, J., Tan, T. L., Zhang, J., Ching, C. B., Chen, W. N., iTRAQ-coupled 2D LC-MS/MS analysis on protein profile in vascular smooth muscle cells incubated with S- and R-enantiomers of propranolol: possible role of metabolic enzymes involved in cellular anabolism and antioxidant activity. J. Proteome Res. 2007, 6, 1643-1651.
19. Zhang, J., Sui, J., Ching, C. B., Chen, W. N., Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics 2008, 8, 1595-1607.
20. Sui, J., Zhang, J., Tan, T. L., Ching, C. B., Chen, W. N., Comparative proteomics analysis of vascular smooth muscle cells incubated with S- and R-enantiomers of atenolol using iTRAQ-coupled two-dimensional LC-MS/MS. Mol. Cell Proteomics 2008, 7, 1007-1018.
21. Li, L. C., Dahiya, R., MethPrimer: designing primers for methylation PCRs. Bioinformatics (Oxford, England) 2002, 18, 1427-1431.
22. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., Baylin, S. B., Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natil. Acad. Sci. USA 1996, 93, 9821-9826.
23. Thomas, M. B., Zhu, A. X., Hepatocellular carcinoma: the need for progress. J. Clin. Oncol. 2005, 23, 2892-2899.
24. Chen, W. N., Oon, C. J., Human hepatitis B virus mutants: significance of molecular changes. FEBS Lett. 1999, 453, 237-242.
25. Sells, M. A., Chen, M. L., Acs, G., Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Nat. Acad. Sci. USA 1987, 84, 1005-1009.
26. Paweletz, C. P., Ornstein, D. K., Roth, M. J., Bichsel, V. E. et al., Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 2000, 60, 6293-6297.
27. Chetcuti, A., Margan, S. H., Russell, P., Mann, S. et al., Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res. 2001, 61, 6331-6334.
28. Liu, J. W., Shen, J. J., Tanzillo-Swarts, A., Bhatia, B. et al., Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 2003, 22, 1475-1485.
29. Dai, Z., Liu, Y. K., Cui, J. F., Shen, H. L. et al., Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics 2006, 6, 5857-5867.
30. Yu, G. R., Kim, S. H., Park, S. H., Cui, X. D. et al., Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma. Exp. Mol. Med. 2007, 39, 641-652.
31. Mohammad, H. S., Kurokohchi, K., Yoneyama, H., Tokuda, M. et al., Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int. J. Oncol. 2008, 33, 1157-1163.
32. Choi, J., Chang, J. S., Song, M. S., Ahn, B. Y. et al., Association of hepatitis B virus polymerase with promyelocytic leukemia nuclear bodies mediated by the S100 family protein p11. Biochem.Biophys. Res. Commun. 2003, 305, 1049-1056.
33. Otegbayo, J. A., Arinola, O. G., Aje, A., Oluwasola, O. A. et al., Usefulness of acute phase proteins for monitoring development of hepatocellular carcinoma in hepatitis B virus carriers. West Afr. J. Med. 2005, 24, 124-127.
34. Zimmer, D. B., Cornwall, E. H., Landar, A., Song, W., The S100 protein family: history, function, and expression. Brain Res. Bull. 1995, 37, 417-429.
35. Donato, R., Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochimica Biophys. Acta 1999, 1450, 191-231.
36. Schafer, B. W., Heizmann, C. W., The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 1996, 21, 134-140.
37. Komatsu, K., Kobune-Fujiwara, Y., Andoh, A., Ishiguro, S. et al., Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br. J. Cancer 2000, 83, 769-774.
38. Rehman, I., Cross, S. S., Azzouzi, A. R., Catto, J. W. et al., S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br. J. Cancer 2004, 91, 739-744.
39. Lindsey, J. C., Lusher, M. E., Anderton, J. A., Gilbertson, R. J. et al., Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma. Br. J. Cancer 2007, 97, 267-274.
40. Kim, J., Kim, J., Yoon, S., Joo, J. et al., S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma. Hepatol. Res. 2002, 23, 274.
41. Melle, C., Ernst, G., Schimmel, B., Bleul, A., von Eggeling, F., Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(21)-binding proteins S100A6 and S100A11. PLoS ONE 2008, 3, e3767.
42. Tong, A., Gou, L., Lau, Q. C., Chen, B. et al., Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis b virus x protein. J. Proteome Res. 2009, 8, 1037-1046.
43. Cascante, M., Centelles, J. J., Veech, R. L., Lee, W. N., Boros, L. G., Role of thiamin (vitamin B-1) and transketolase in tumor cell proliferation. Nutr. Cancer 2000, 36, 150-154.
44. Kinoshita, M., Miyata, M., Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. Hepatology (Baltimore, Md.) 2002, 36, 433-438.